These sites and apps can help you save money on clothes and products your kids will soon outgrow, and they help the environment by reducing waste.

So it’s not at all surprising to see Eli Health announce Hormometer, an at-home hormone-testing system that uses your spit and your smartphone’s camera to measure hormone levels. Like many at ...

Philadelphia native Nancy Marie Gilliam is nominated for a Pulitzer Prize for her play ... reports say The Best Place To Use A Curio Cabinet In Your Home (& How To Style It Like A Designer ...

In “Lilly,” writer-director Rachel Feldman follows the era-defining work of one such everyday woman: trailblazer Lilly Ledbetter, a pioneer from humble beginnings who took her employer ...

A Pulitzer Prize-winning cartoonist for the Washington Post has resigned after its editorial page editor rejected a cartoon she created to mock media and tech titans abasing themselves before ...

Pulitzer Prize-winning cartoonist Ann Telnaes is leaving the Washington Post after nearly two decades due to what she claims was editorial interference at the paper. In a post to her Substack on ...

Telnaes, who won a Pulitzer Prize for Editorial Cartooning in 2001, has long been an advocate for free speech and editorial cartoons as a tool for civic debate. She serves on the advisory board ...

Ann Telnaes, a Pulitzer Prize-winning cartoonist for The Washington Post, said Friday evening that she was resigning after the newspaper’s opinions section rejected a cartoon depicting Post ...

In the new filing, Lilly says it wants to wade into the legal proceedings to “protect its interests and help bring this suit to a swift end.” The company’s lawyers further contend that OFA ...

Since Zepbound was approved by the FDA to treat obesity in late 2023, its maker Eli Lilly has been steadily closing in on fierce rival Novo Nordisk’s early lead in the obesity market.

Lilly seeks to protect interests in compounded drug case FDA affirms no shortage of tirzepatide drugs Compounded versions cheaper, often not covered by insurers Jan 2 (Reuters) - Eli Lilly (LLY.N ...

Senior equity analysts at StockNews.com upgraded Eli Lilly (LLY, Financial) stock from 'hold' to 'buy' as its stock has shifted positively. Analysts say the upgrade is a sign of increased ...